STOCK TITAN

LeMaitre Vascular (NASDAQ: LMAT) CEO gifts 11,974 shares, receives dividend rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC Chairman and CEO George W. LeMaitre reported a mix of estate-planning and compensation-related equity movements in company securities. He made a bona fide gift of 11,974 shares of common stock, after which his direct holdings stood at 1,418,045 common shares. A related irrevocable life insurance trust for the benefit of his children holds 45,374 common shares, and he disclaims beneficial ownership except for any pecuniary interest. In addition, he received several small grants of dividend equivalent rights tied to prior restricted stock unit and performance share unit awards, each economically equivalent to one share of common stock and vesting proportionately with the underlying awards.

Positive

  • None.

Negative

  • None.
Insider LeMaitre George W
Role Chairman and CEO
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights 4.009 $0.00 --
Grant/Award Dividend Equivalent Rights 4.009 $0.00 --
Grant/Award Dividend Equivalent Rights 6.854 $0.00 --
Grant/Award Dividend Equivalent Rights 8.214 $0.00 --
Grant/Award Dividend Equivalent Rights 10.025 $0.00 --
Grant/Award Dividend Equivalent Rights 11.359 $0.00 --
Grant/Award Dividend Equivalent Rights 16.805 $0.00 --
Gift Common Stock 11,974 $0.00 --
Grant/Award Common Stock 11,974 $0.00 --
Holdings After Transaction: Dividend Equivalent Rights — 49.332 shares (Direct, null); Common Stock — 1,418,045 shares (Direct, null); Common Stock — 45,374 shares (Indirect, LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025)
Footnotes (1)
  1. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Common shares gifted 11,974 shares Bona fide gift of common stock on 2026-06-04
Direct common shares after gift 1,418,045 shares Direct LMAT common stock holdings after 2026-06-04
Trust common shares after acquisition 45,374 shares Held by LeMaitre Irrevocable Life Insurance Trust of 2025
Dividend equivalent rights grant 16.8053 rights Accrued on 12/12/2022 RSU award
Dividend equivalent rights grant 11.3593 rights Accrued on 12/12/2022 PSU award
Dividend equivalent rights balance 60.8553 rights One direct holding balance after 2026-06-04
Dividend equivalent rights balance 57.3460 rights Another direct holding balance after 2026-06-04
Dividend Equivalent Rights financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award."
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
bona fide gift financial
"transaction_code_description: "Bona fide gift""
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
restricted stock unit award financial
"These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
performance share unit award financial
"These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award."
irrevocable trust financial
"These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren)."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LeMaitre George W

(Last)(First)(Middle)
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE

(Street)
BURLINGTON MASSACHUSETTS 01803

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chairman and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026G11,974D$01,418,045D
Common Stock06/04/2026A11,974A$045,374ILEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(2)06/04/2026A4.0092 (2) (2)Common Stock4.0092$049.3324D
Dividend Equivalent Rights(3)06/04/2026A4.0092 (3) (3)Common Stock4.0092$048.6237D
Dividend Equivalent Rights(4)06/04/2026A6.854 (4) (4)Common Stock6.854$057.346D
Dividend Equivalent Rights(5)06/04/2026A8.2136 (5) (5)Common Stock8.2136$060.8553D
Dividend Equivalent Rights(6)06/04/2026A10.0254 (6) (6)Common Stock10.0254$053.3794D
Dividend Equivalent Rights(7)06/04/2026A11.3593 (7) (7)Common Stock11.3593$053.8418D
Dividend Equivalent Rights(8)06/04/2026A16.8053 (8) (8)Common Stock16.8053$031.0239D
Explanation of Responses:
1. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
2. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
6. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
8. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ Laurie A. Churchill, Attorney-in-fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did LMAT CEO George LeMaitre report on this Form 4?

George LeMaitre reported a bona fide gift of 11,974 LMAT common shares and several small grants of dividend equivalent rights. The gift reduced his direct holdings but left him owning 1,418,045 common shares directly after the transactions.

How many LEMAITRE VASCULAR (LMAT) shares does the CEO hold after the reported transactions?

After these transactions, George LeMaitre directly holds 1,418,045 shares of LMAT common stock. An additional 45,374 shares are held by an irrevocable trust for his children, for which he disclaims beneficial ownership except for any pecuniary interest.

What is the significance of the 11,974-share gift reported for LMAT?

The filing shows a bona fide gift of 11,974 LMAT common shares from George LeMaitre. Following the gift, he still directly owns 1,418,045 shares, indicating this is a relatively small transfer compared with his remaining direct position.

What are dividend equivalent rights mentioned in the LMAT Form 4 filing?

Dividend equivalent rights in this filing are awards that are economically equivalent to one LMAT common share each. They accrued on prior restricted stock unit and performance share unit grants and vest proportionately with those underlying awards, effectively tracking dividends on those shares.

How many LMAT dividend equivalent rights did the CEO receive in these transactions?

George LeMaitre received several small grants of dividend equivalent rights, including awards of 16.8053, 11.3593, 10.0254, 8.2136, 6.8540 and 4.0092 units. After these grants, different related accounts show balances such as 60.8553 and 57.3460 dividend equivalent rights.

Who holds the LMAT shares in the irrevocable life insurance trust mentioned in the Form 4?

The shares are held by the LeMaitre Irrevocable Life Insurance Trust of 2025, established for the benefit of the reporting person’s children. The Form 4 states that George LeMaitre disclaims beneficial ownership except to the extent of any pecuniary interest.